Tag: Berkeley Heights

Mergers and Acquisitions (M&A): CorMedix Inc. (CorMedix) (NASDAQ: CRMD) Acquires Melinta Therapeutics for $300 Million.

Mergers and Acquisitions (M&A): CorMedix Inc. (CorMedix) (NASDAQ: CRMD) Acquires Melinta Therapeutics for $300 Million.

CorMedix Inc. has announced the acquisition of Melinta Therapeutics. According to the company announcement CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions…

Read More Read More

Cyclacel Pharmaceuticals has filed a notice of an exempt offering of securities to raise $8 Million in New Equity Investment.

Cyclacel Pharmaceuticals has filed a notice of an exempt offering of securities to raise $8 Million in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Cyclacel Pharmaceuticals is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Spiro Rombotis played a…

Read More Read More